Please use a PC Browser to access Register-Tadawul
Get It
A Peek at Quoin Pharmaceuticals's Future Earnings
Quoin Pharmaceuticals, Ltd. - American Depositary Shares -0.24%
Quoin Pharmaceuticals, Ltd. - American Depositary Shares QNRX | 8.47 | -0.24% |
Quoin Pharmaceuticals (NASDAQ:QNRX) will release its quarterly earnings report on Tuesday, 2025-05-13. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Quoin Pharmaceuticals to report an earnings per share (EPS) of $-4.20.
Anticipation surrounds Quoin Pharmaceuticals's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Historical Earnings Performance
Last quarter the company beat EPS by $0.08, which was followed by a 3.17% increase in the share price the next day.
Here's a look at Quoin Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.43 | -0.49 | -0.61 | -0.76 |
| EPS Actual | -0.35 | -0.47 | -0.39 | -1.11 |
| Price Change % | 3.0% | -3.0% | -5.0% | -3.0% |
Tracking Quoin Pharmaceuticals's Stock Performance
Shares of Quoin Pharmaceuticals were trading at $6.19 as of May 09. Over the last 52-week period, shares are down 76.93%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Quoin Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
